Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für Infektionsbiologie     Collection: Department of Immunology     Display Documents



  history
ID: 532892.0, MPI für Infektionsbiologie / Department of Immunology
Novel tuberculosis vaccines on the horizon
Authors:Parida, Shreemanta K.; Kaufmann, Stefan H. E.
Language:English
Date of Publication (YYYY-MM-DD):2010-06
Title of Journal:Current Opinion in Immunology
Journal Abbrev.:Curr. Opin. Immunol.
Volume:22
Issue / Number:3
Start Page:374
End Page:384
Copyright:Copyright © 2010 Elsevier Ltd All rights reserved.
Review Status:Peer-review
Audience:Experts Only
Comment of the Author/Creator:Acknowledgements
Studies on TB vaccines and biomarkers in the authors’ laboratory received financial support from the following: Bill & Melinda Gates Foundation Grand Challenges in Global Health Grant No. 37772, National Institute of Health NIH SysBiol Contract, the European Union Framework Program 6 Projects, Design and Testing of Vaccine Candidates against Tuberculosis (TBVAC); LSIP-CT-2003-503367; EU FP7 Project NEW-TBVAC HEALTH-2009-241745 on Discovery and Pre-clinical Development of New Generation TB Vaccine; and Bundesministerium für Bildung und Forschung Networks PathoGenoMikPlus and Nationales Genomforschungsnetz (NGFN).
External Publication Status:published
Document Type:Article
Version Comment:Automatic journal name synchronization
Communicated by:Hilmar Fünning
Affiliations:MPI für Infektionsbiologie/Department of Immunology
Identifiers:ISI:000279425500017 [ID No:1]
ISSN:0952-7915 [ID No:2]
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.